東方生物(688298.SH)：6款新型冠狀病毒檢測產品獲得歐盟CE認證
格隆匯 3 月 10日丨東方生物(688298.SH)公佈，公司於近期取得了以下6款新型冠狀病毒檢測產品的歐盟CE認證。產品名稱分別為SARS-CoV-2 Ab & NAb Combo RapidTest Cassette(WholeBlood/Serum/Plasma)新型冠狀病毒總抗體和中和抗體聯合檢測試紙(膠體金法)、COVID-19 Antibody Rapid Test Cassette(Whole Blood/Serum/Plasma)(新型冠狀病毒總抗體檢測試劑(膠體金法))、SARS-CoV-2 Neutralizing AntibodyRapid Test Cassette(WholeBlood/Serum/Plasma)(新型冠狀病毒中和抗體檢測試劑(膠體金法))、SARS-CoV-2 K417N/E484K MutationsDetection Kit (Fluorescence PCR)(新型冠狀病毒K417N和E484K基因突變檢測試劑盒(熒光PCR法))、SARS-CoV-2 N501Y/HV69-70delMutations Detection Kit (FluorescencePCR)(新型冠狀病毒N501Y和HV69-70del基因突變檢測試劑盒(熒光PCR法))、SARS-CoV-2 & Influenza A/B DetectionKit (Direct Fluorescence PCR)(新型冠狀病毒和甲乙型流感聯合檢測試劑(熒光PCR法))。
公司全力支持新冠防控事業，積極響應新冠檢測產品需求，此次新增6款新冠檢測產品，截止目前公司已累計取得11款新冠檢測產品歐盟CE認證，進一步豐富了公司新冠檢測產品系列，滿足疫情不斷髮展變化的檢測需求，對公司海外業務拓展和產品銷售有積極的影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
